David Gallinson
About
In The Last Decade
David Gallinson
17 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 49
- Surgery 813
- Oncology 624
- Pulmonary and Respiratory Medicine 380
- Molecular Biology 332
- Pathology and Forensic Medicine 177
Countries citing papers authored by David Gallinson
This map shows the geographic impact of David Gallinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gallinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gallinson more than expected).
Fields of papers citing papers by David Gallinson
This network shows the impact of papers produced by David Gallinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gallinson. The network helps show where David Gallinson may publish in the future.
Co-authorship network of co-authors of David Gallinson
This figure shows the co-authorship network connecting the top 25 collaborators of David Gallinson. A scholar is included among the top collaborators of David Gallinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gallinson. David Gallinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 16 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 17 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 19 | |
| 11 | 5 | |
| 12 | Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study breakdown → | 975 |
| 13 | 2 | |
| 14 | 42 | |
| 15 | 30 | |
| 16 | 1 | |
| 17 | Clinical practice issues in oncology impacted by healthcare reform. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.